Table 2.

Characterization parameters of different liposomal formulations of mTHPC.

Formulation	EE (%)	Size (nm)	Polydispersity Index	Zeta-Potential (mV)
Foslip®	>85 [16]	113.6 ± 0.7	0.110 ± 0.015	−34.4 ± 4.3
DCLs with Hp-β-CD
HDCL 1	7	137.7 ± 3.3	0.067 ± 0.030	−38.1 ± 1.9
HDCL 2	13	128.5 ± 0.3	0.037 ± 0.015	−36.7 ± 0.8
HDCL 3	17	125.7 ± 0.9	0.050 ± 0.004	−37.3 ± 1.6
DCLs with Me-β-CD
MDCL 1	5	132.7 ± 0.8	0.045 ± 0.012	−37.8 ± 1.8
MDCL 2	7	141.0 ± 2.2	0.101 ± 0.019	−39.0 ± 2.6
MDCL 3	9	142.2 ± 0.8	0.073 ± 0.022	−36.4 ± 0.9
DCLs with TM-β-CD
TDCL 1	7	135.9 ± 1.4	0.101 ± 0.034	−38.1 ± 1.2
TDCL 2	9	139.2 ± 0.9	0.065 ± 0.017	−36.9 ± 1.5
TDCL 3	14	130.6 ± 1.3	0.078 ± 0.026	−37.3 ± 2.1